U.S. Drug Spending Will Increase 7.6% in 2015, Including PCSK9 Costs – CMS
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency expects PCSK9 drugs for cholesterol will have relatively “modest” impact on drug spending across commercial and government payers in 2015, actuaries explain.